Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Nov/14/2020 Nov/27/2020 0
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/10/2020 Nov/24/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Rutin Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 Nov/24/2020 0
MB_241 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 Nov/24/2020 0
MB_250 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 Nov/24/2020 0
MB_266 Potential treatment - theoretical effect Experimental Antiviral Oct/24/2020 Nov/24/2020 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Oct/23/2020 Nov/24/2020 0
Cyanidin-3-O-glucoside Potential treatment - pre-clinical evidence Natural product Antiviral Oct/23/2020 Nov/24/2020 0